Violetta Cotreau's Insider Trades & SAST Disclosures
Violetta Cotreau's most recent trade in Akebia Therapeutics Inc. was a trade of 150,000 Common Stock done . Disclosure was reported to the exchange on May 12, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Violetta Cotreau.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc. | Violetta Cotreau | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 150,000 | 219,954 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | Violetta Cotreau | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | Violetta Cotreau | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 40,833 | 69,954 (0%) | 0% | 0 | Common Stock | |
| Akebia Therapeutics Inc. | Violetta Cotreau | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 2.15 per share. | 28 Feb 2022 | 3,946 | 29,121 (0%) | 0% | 2.2 | 8,503 | Common Stock |
| Akebia Therapeutics Inc. | Violetta Cotreau | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 2.29 per share. | 03 Jan 2022 | 5,833 | 33,067 (0%) | 0% | 2.3 | 13,335 | Common Stock |
| Akebia Therapeutics Inc. | Violetta Cotreau | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 44,200 | 44,200 | - | - | Employee Stock Option (Right to buy) | |
| Akebia Therapeutics Inc. | Violetta Cotreau | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 26,000 | 38,900 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges